Dr. Delgardo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison St
Ste 855
Chicago, IL 60612Phone+1 312-942-6644
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsClass of 2024, MD
Xavier University of LouisianaBS, Biology, Summa Cum Laude; Honors in Biology, Chemistry, and Mathematics; Rousseve Scholar, 2015 - 2019
Certifications & Licensure
IL State Medical License 2024 - 2027
Publications & Presentations
PubMed
- Optimizing Surgical Outcomes for Intracranial Epidermoid Tumors: A Retrospective Analysis of Clinical Predictors, Surgical Decisions, and Patient Clustering.Mychael W Delgardo, Damian E Teasley, Anthony J Tang, Chiemela Izima, Brianna M Peet
World Neurosurgery. 2024-10-01 - Timing of intraoperative neurophysiological monitoring (IONM) recovery and clinical recovery after termination of pediatric spinal deformity surgery due to loss of ION...Travis S CreveCoeur, Rajiv R Iyer, Hannah E Goldstein, Mychael W Delgardo, Todd C Hankinson
The Spine Journal. 2024-09-01 - Awake intraoperative mapping for the prevention of amusia.Linda Wang, Dominique Higgins, Mychael Delgardo, Cory Chang, Marla J Hamberger
Neurosurgical Focus. 2024-02-01
Journal Articles
- Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent...Biliran, Hector, Delgardo, Mychael, Yao, Xin, et al., Biochemical and Biophysical Research Communications, 2017
Abstracts/Posters
- Downregulation of the tumor suppressor Bit1 expression in human lung cancer cells promotes FAK activation and leads to susceptibility to the growth inhibitory effect o...Biliran, Hector, Delgardo, Mychael, Yao, Xin, et. al, 2019 Louisiana Cancer Research Consortium Scientific Retreat, New Orleans, Louisiana, 2019
- The transcriptional corepressor TLE1 as a driver of Epithelial-Mesenchymal Transition (EMT) and hormonal therapy resistance in breast cancerBiliran, Hector, Delgardo, Mychael, Yao, Xin, et. al, 2018 Louisiana Cancer Research Consortium Scientific Retreat, New Orleans, Louisiana, 2018
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
